IRWD · Ironwood Pharmaceuticals Inc
United States · RS rating 31 · As of 2026-10-14
| Price | 3.60 USD |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 21 / 38 / 97 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 39 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -104.3% |
| Sales growth Q/Q | -60.9% |
| Distance from 52-week high | +33.2% |
| Market cap (USD) | $618.0M |